Skip to main navigation Skip to search Skip to main content

Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?

  • Henning Wackerhage*
  • , Ivan J. Vechetti
  • , Philipp Baumert
  • , Sebastian Gehlert
  • , Lore Becker
  • , Richard T. Jaspers
  • , Martin Hrabě de Angelis
  • *Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

In 1924, Otto Warburg asked “How does the metabolism of a growing tissue differ from that of a non-growing tissue?” Currently, we know that proliferating healthy and cancer cells reprogramme their metabolism. This typically includes increased glucose uptake, glycolytic flux and lactate synthesis. A key function of this reprogramming is to channel glycolytic intermediates and other metabolites into anabolic reactions such as nucleotide-RNA/DNA synthesis, amino acid-protein synthesis and the synthesis of, for example, acetyl and methyl groups for epigenetic modification. In this review, we discuss evidence that a hypertrophying muscle similarly takes up more glucose and reprogrammes its metabolism to channel energy metabolites into anabolic pathways. We specifically discuss the functions of the cancer-associated enzymes phosphoglycerate dehydrogenase and pyruvate kinase muscle 2 in skeletal muscle. In addition, we ask whether increased glucose uptake by a hypertrophying muscle explains why muscularity is often negatively associated with type 2 diabetes mellitus and obesity.

Original languageEnglish
Pages (from-to)2569-2578
Number of pages10
JournalSports Medicine
Volume52
Issue number11
Early online date23 Apr 2022
DOIs
Publication statusPublished - Nov 2022

Bibliographical note

Funding Information:
Open Access funding enabled and organized by Projekt DEAL. PB is supported by the EuroTech Postdoc Programme (Grant Agreement Number 754462), co-funded by the European Commission under its framework programme Horizon 2020. Work on this research (HW, PB) is additionally supported by a grant to the Deutsche Diabetes Stiftung.

Publisher Copyright:
© 2022, The Author(s).

Funding

Open Access funding enabled and organized by Projekt DEAL. PB is supported by the EuroTech Postdoc Programme (Grant Agreement Number 754462), co-funded by the European Commission under its framework programme Horizon 2020. Work on this research (HW, PB) is additionally supported by a grant to the Deutsche Diabetes Stiftung.

FundersFunder number
Deutsche Diabetes Stiftung
EuroTech Postdoc Programme
Horizon 2020 Framework Programme754462
European Commission

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?'. Together they form a unique fingerprint.

    Cite this